Prostate Cancer

Through Malecare, men are coming together to fight prostate cancer.

Many advances have been made in the fight against prostate cancer in the past two decades, but ZERO will not stop until the disease is completely ended.

Choosing the right treatment option for prostate cancer can be overwhelming, and sometimes a lack of information or second opinion can lead to a wrong decision.

An essay from our Extraordinary Healers book honoring Sharon Bernico, RN, OCN [Oncology Therapy Center in Morris, Illinois].

The designation is based on data from the phase 2 TOPARP-A trial that demonstrated that Lynparza monotherapy had an overall response rate of nearly 90 percent in a biomarker-defined subgroup of patients who had DNA-repair defects.

A legendary cornerback in the NFL, former New England Patriots and Los Angeles Raiders star Mike Haynes is no stranger to going to battle on the gridiron.

Despite the fact that it has been three years since the drug was approved by the FDA, many oncologists still need to be educated regarding Xofigo's benefits beyond pain palliation,

Among undiagnosed men who took regular aspirin, the risk of developing a lethal form of prostate cancer was reduced by 24 percent.

Men with prostate cancer may be eligible to join a patient registry that will track their treatment choices and outcomes, as well as quality-of-life measures and the health of their caregivers over time.

When diagnosing prostate cancer, doctors consider staging and grading. In grading, a score is assigned based on the Gleason grading system.

Understanding state-of-the-art care helps patients with prostate cancer to choose treatments

New advances in radiation treatment enable higher doses with less damage to nearby tissue.

Medical and scientific communities continue to weigh the value of PSA screening

BRCA mutations can lead to prostate and other cancers, and men are as likely as women to inherit them. Yet male awareness is lagging.

Whether to opt for surgery or radiation to treat localized prostate cancer depends mainly on the stage and grade of disease.

New drug treatments are helping patients with advanced prostate cancer to live longer.

Innovative approaches offer more surgical options with potentially fewer side effects.

Sexual activity after prostate cancer therapy might be different, but still possible.

New ways to find prostate cancer and gauge its aggressiveness help patients make better choices.